SK Biopharmaceuticals Co. on Thursday reported its second-quarter net profit of 24.6 billion won (US$17.8 million), turning from a loss of 23.3 billion won a year earlier. Operating profit for the April-June period was 26 billion, compared with a loss of 18.9 billion won a year ago, the company said in a regulatory filing. Revenue rose 74 percent to 134 billion won. The operating profit was 103.8 percent higher than the average estimate, according to a survey by Yonhap Infomax, the financial data firm of Yonhap News Agency. The estimate of net profit was not available. Source : Yonhap News Agency
SK Biopharmaceuticals swings to profits in Q2
Deputy Minister of Education Addresses Assault Incident in Kanchanaburi
November 20, 2026
Democrat Party Demands Government Clarify Solar Program Delays
November 20, 2026
Muhammad Usman Musa Wins 2026 Asian Futsal Player of the Year Award
November 20, 2026
Ministry of Justice Launches New Channels for Legal Assistance
November 20, 2026